AVTR
Avantor, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+44/100
Last price
15.43
▼ 0.38 (2.40%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
15.81
Day high
16.38
Day low
15.43
Volume
11.39M
Market cap
$10.44B
P/E (TTM)
—
52W range
7.27 – 16.38
Trailing performance
Returnvs SPY
1W
+1.25%
-0.7%
1M
+3.07%
+1.9%
3M
+58.09%
+53.6%
6M
+92.88%
+74.7%
YTD
+34.64%
+20.4%
1Y
+7.98%
-8.4%
3Y
-26.80%
-109.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AVTR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+27.79M
Net buying
Buy transactions
17
73.85M shares
Sell transactions
4
46.06M shares
Net transactions
+21
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
10.33M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 21, 26 | GARNER TODD W. Chief Financial Officer |
STOCK | 49.69K | $0 | Direct |
| May 8, 26 | LUCIER GREGORY T Director |
BUY | 10.00K | $83.20K | Indirect |
| May 7, 26 | MURTHY MALA Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | DINGEMANS SIMON Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | MAKIN LOUISE Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | MASSARO JOSEPH R Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | SEVERINO MICHAEL E Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | MEHRA SANJEEV K Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | LUCIER GREGORY T Director |
STOCK | 25.27K | $0 | Direct |
| May 7, 26 | SUMME GREGORY L Director |
STOCK | 25.27K | $0 | Direct |
| May 1, 26 | BRELLIER LUDOVIC Officer |
STOCK | 146.57K | $0 | Direct |
| May 1, 26 | DINGEMANS SIMON Director |
BUY | 25.00K | $203.50K | Indirect |
| Apr 2, 26 | ECK STEVEN W. Officer |
STOCK | 31.64K | $0 | Direct |
| Mar 10, 26 | MEHRA SANJEEV K Director |
BUY | 125.00K | $1.00M | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLENN MARY |
Chief Operating Officer | 253.38K | Stock Award(Grant) |
GOURDIER BENOIT |
Officer | 365.89K | Stock Award(Grant) |
HANKAMER BRITTANY |
Officer | 250.73K | Stock Award(Grant) |
JONES R BRENT |
Chief Financial Officer | 422.59K | Stock Award(Grant) |
LIGNER EMMANUEL |
Chief Executive Officer | 767.14K | Stock Award(Grant) |
MEHRA SANJEEV K |
Director | 508.38K | Stock Award(Grant) |
SOKENU CLAUDIUS O. |
Officer | 254.81K | Stock Award(Grant) |
STUBBLEFIELD MICHAEL |
Chief Executive Officer | 1.92M | Stock Gift |
SUMME GREGORY L |
Director | 483.38K | Stock Award(Grant) |
WALKER COREY |
Officer | 387.55K | Stock Award(Grant) |
Fundamentals
Market cap$10.44B
Enterprise value$13.83B
Revenue (TTM)$6.56B
Gross profit$2.09B
EBITDA$943.70M
Net income$-578.00M
EPS (TTM)$-0.82
Free cash flow$450.34M
Total cash$306.80M
Total debt$3.70B
Book value / share$8.32
Shares outstanding676.36M
Float657.81M
Short % of float9.22%
Dividend yield0.00%
Beta (5Y)0.94
Valuation & profitability ratios
Trailing P/E—
Forward P/E17.59
PEG ratio—
Price / sales—
Price / book1.85
EV / revenue2.11
EV / EBITDA14.65
Gross margin31.82%
Operating margin7.16%
Profit margin-8.81%
Return on equity-9.70%
Return on assets2.69%
Debt / equity65.68
Current ratio1.78
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $6.55B | $6.78B | $6.97B | $7.51B | -3.4% |
| Operating revenue | $6.55B | $6.78B | $6.97B | $7.51B | -3.4% |
| Cost of revenue | $4.41B | $4.50B | $4.60B | $4.91B | -2.0% |
| Gross profit | $2.14B | $2.28B | $2.36B | $2.60B | -6.1% |
| Selling, general & admin | $1.60B | $1.64B | $1.51B | $1.47B | -2.8% |
| Total operating expense | $1.60B | $1.64B | $1.51B | $1.47B | -2.8% |
| Operating income | $543.90M | $638.20M | $857.20M | $1.13B | -14.8% |
| Net interest income | -$169.80M | -$218.80M | -$284.80M | -$265.80M | +22.4% |
| Pre-tax income | -$441.30M | $853.90M | $410.50M | $851.10M | -151.7% |
| Tax provision | $88.90M | $142.40M | $89.40M | $164.60M | -37.6% |
| Net income | -$530.20M | $711.50M | $321.10M | $686.50M | -174.5% |
| Net income to common | -$530.20M | $711.50M | $321.10M | $662.30M | -174.5% |
| Basic EPS | -0.78 | 1.05 | 0.48 | 1.02 | -174.3% |
| Diluted EPS | -0.78 | 1.04 | 0.47 | 1.01 | -175.0% |
| EBIT | -$271.50M | $1.07B | $695.30M | $1.12B | -125.3% |
| EBITDA | $138.70M | $1.48B | $1.10B | $1.52B | -90.6% |
| Basic shares | 680.60M | 679.60M | 675.60M | 650.90M | +0.1% |
| Diluted shares | 680.60M | 681.90M | 678.40M | 679.40M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $365.40M | $261.90M | $262.90M | $372.90M | +39.5% |
| Cash & short-term investments | $365.40M | $261.90M | $262.90M | $372.90M | +39.5% |
| Accounts receivable | $1.07B | $1.03B | $1.15B | $1.22B | +3.9% |
| Inventory | $818.20M | $731.50M | $828.10M | $913.50M | +11.9% |
| Total current assets | $2.45B | $2.15B | $2.38B | $2.66B | +14.2% |
| Property, plant & equipment | $766.80M | $708.10M | $737.50M | $727.00M | +8.3% |
| Goodwill & intangibles | $8.18B | $8.90B | $9.49B | $9.79B | -8.1% |
| Total assets | $11.79B | $12.11B | $12.97B | $13.46B | -2.6% |
| Total current liabilities | $1.38B | $2.01B | $1.48B | $1.66B | -31.3% |
| Current debt | $30.80M | $821.10M | $259.90M | $364.20M | -96.2% |
| Long-term debt | $3.92B | $3.23B | $5.28B | $5.92B | +21.0% |
| Total debt | $3.95B | $4.06B | $5.54B | $6.29B | -2.7% |
| Total liabilities | $6.23B | $6.16B | $7.72B | $8.61B | +1.2% |
| Retained earnings | $1.67B | $2.20B | $1.49B | $1.17B | -24.1% |
| Shareholder equity | $5.57B | $5.96B | $5.25B | $4.86B | -6.6% |
| Working capital | $1.07B | $139.10M | $904.60M | $999.10M | +670.9% |
| Net tangible assets | -$2.62B | -$2.94B | -$4.24B | -$4.93B | +11.1% |
| Shares issued | 688.60M | 680.80M | 676.60M | 674.30M | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$530.20M | $711.50M | $321.10M | $686.50M | — | -174.5% |
| Depreciation & amortisation | $410.20M | $405.50M | $402.30M | $405.50M | — | +1.2% |
| Stock-based compensation | $46.40M | $46.80M | $40.50M | $45.80M | — | -0.9% |
| Change in working capital | -$198.90M | $47.70M | $16.60M | -$321.30M | — | -517.0% |
| Operating cash flow | $623.80M | $840.80M | $870.00M | $843.60M | — | -25.8% |
| Capital expenditure | -$128.80M | -$148.80M | -$146.40M | -$133.40M | — | +13.4% |
| Investing cash flow | -$130.50M | $438.90M | -$143.70M | -$109.60M | — | -129.7% |
| Share buybacks | -$80.70M | -$8.60M | -$13.70M | -$13.20M | — | -838.4% |
| Dividends paid | — | $0 | $0 | -$32.40M | -$64.60M | — |
| Financing cash flow | -$409.40M | -$1.28B | -$843.70M | -$648.70M | — | +68.0% |
| Free cash flow | $495.00M | $692.00M | $723.60M | $710.20M | — | -28.5% |
| End cash position | $368.30M | $264.70M | $287.70M | $396.90M | — | +39.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | +7.0% |
| Operating revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | +7.0% |
| Cost of revenue | $1.16B | $1.08B | $1.14B | $1.10B | $1.13B | +6.9% |
| Gross profit | $537.00M | $500.70M | $523.90M | $526.50M | $554.10M | +7.2% |
| Selling, general & admin | $415.20M | $401.20M | $392.40M | $390.30M | $425.30M | +3.5% |
| Total operating expense | $415.20M | $401.20M | $392.40M | $390.30M | $425.30M | +3.5% |
| Operating income | $121.80M | $99.50M | $131.50M | $136.20M | $128.80M | +22.4% |
| Net interest income | -$39.40M | -$42.90M | -$40.00M | -$44.20M | -$43.40M | +8.2% |
| Pre-tax income | $81.20M | $55.50M | $80.80M | -$689.50M | $81.70M | +46.3% |
| Tax provision | $43.10M | $12.20M | $28.40M | $22.30M | $17.00M | +253.3% |
| Net income | $38.10M | $43.30M | $52.40M | -$711.80M | $64.70M | -12.0% |
| Net income to common | $38.10M | $43.30M | $52.40M | -$711.80M | $64.70M | -12.0% |
| Basic EPS | 0.06 | 0.06 | 0.08 | -1.04 | 0.09 | 0.0% |
| Diluted EPS | 0.06 | 0.06 | 0.08 | -1.04 | 0.09 | 0.0% |
| EBIT | $120.60M | $98.40M | $120.80M | -$645.30M | $125.10M | +22.6% |
| EBITDA | $226.20M | $203.40M | $224.10M | -$540.80M | $227.80M | +11.2% |
| Basic shares | 676.20M | 675.70M | 678.00M | 681.70M | 681.50M | +0.1% |
| Diluted shares | 677.20M | 676.80M | 679.30M | 681.70M | 681.80M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $306.80M | $279.30M | $365.40M | $251.90M | $449.40M | +9.8% |
| Cash & short-term investments | $306.80M | $279.30M | $365.40M | $251.90M | $449.40M | +9.8% |
| Accounts receivable | $1.14B | $1.10B | $1.07B | $1.08B | $1.15B | +3.1% |
| Inventory | $828.70M | $810.30M | $818.20M | $795.50M | $779.80M | +2.3% |
| Total current assets | $2.46B | $2.40B | $2.45B | $2.26B | $2.51B | +2.4% |
| Property, plant & equipment | $772.10M | $766.20M | $766.80M | $761.60M | $759.00M | +0.8% |
| Goodwill & intangibles | $7.95B | $8.05B | $8.18B | $8.25B | $9.11B | -1.3% |
| Total assets | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | -0.6% |
| Total current liabilities | $1.38B | $1.37B | $1.38B | $1.52B | $2.58B | +1.1% |
| Current debt | $37.00M | $37.00M | $30.80M | $219.80M | $1.25B | 0.0% |
| Long-term debt | $3.66B | $3.78B | $3.92B | $3.64B | $2.99B | -3.1% |
| Total debt | $3.70B | $3.82B | $3.95B | $3.86B | $4.24B | -3.1% |
| Total liabilities | $5.97B | $6.07B | $6.23B | $6.11B | $6.49B | -1.8% |
| Retained earnings | $1.75B | $1.72B | $1.67B | $1.62B | $2.33B | +2.2% |
| Shareholder equity | $5.63B | $5.59B | $5.57B | $5.57B | $6.29B | +0.7% |
| Working capital | $1.08B | $1.04B | $1.07B | $740.70M | -$61.10M | +4.2% |
| Net tangible assets | -$2.32B | -$2.46B | -$2.62B | -$2.68B | -$2.83B | +5.8% |
| Shares issued | 676.50M | 689.50M | 688.60M | 681.90M | 681.60M | -1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $38.10M | $43.30M | $52.40M | -$711.80M | $64.70M | -12.0% |
| Depreciation & amortisation | $105.60M | $105.00M | $103.30M | $104.50M | $102.70M | +0.6% |
| Stock-based compensation | $15.40M | $8.60M | $11.30M | $7.20M | $15.50M | +79.1% |
| Change in working capital | -$22.10M | -$100.40M | -$97.50M | $20.00M | -$30.40M | +78.0% |
| Operating cash flow | $178.20M | $58.70M | $152.70M | $207.40M | $154.40M | +203.6% |
| Capital expenditure | -$37.60M | -$33.50M | -$35.50M | -$35.70M | -$29.60M | -12.2% |
| Investing cash flow | -$37.30M | -$32.70M | -$39.70M | -$33.30M | -$28.60M | -14.1% |
| Share buybacks | -$300.00K | -$3.60M | -$75.30M | -$400.00K | -$100.00K | +91.7% |
| Financing cash flow | -$112.40M | -$107.20M | $700.00K | -$369.60M | -$6.90M | -4.9% |
| Free cash flow | $140.60M | $25.20M | $117.20M | $171.70M | $124.80M | +457.9% |
| End cash position | $309.70M | $282.20M | $368.30M | $254.70M | $452.20M | +9.7% |
Options analytics
Put / call volume
0.13
Call-heavy session
Put / call open interest
0.02
Positioning, not flow
Max pain
12.00
-22.2% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
220
Contracts, this expiry
Put volume
28
Contracts, this expiry
Heaviest call OI
15.00
40.47K contracts
Heaviest put OI
13.00
1.70K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.19 | 0.21 | +11.1% |
| Mar 2026 | 0.16 | 0.17 | +8.2% |
| Dec 2025 | 0.22 | 0.22 | +1.5% |
| Sep 2025 | 0.23 | 0.22 | -2.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.21 | 16 | $1.64B | +1.1% |
| Next quarter | 0.22 | 15 | $1.68B | +0.8% |
| Current year | 0.81 | 16 | $6.59B | +0.6% |
| Next year | 0.88 | 16 | $6.75B | +2.3% |
Analyst targets & ownership
Mean target$14.78
High target$19.00
Low target$12.00
Implied upside-4.22%
Analyst count14
ConsensusHOLD
Strong buy / Buy0 / 2
Hold13
Sell / Strong sell0 / 1
Held by insiders1.53%
Held by institutions105.41%
Institutions holding603
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
15.26
+1.13% from price
SMA 20
15.24
+1.25% from price
SMA 50
14.53
+6.22% from price
SMA 100
12.11
+27.40% from price
SMA 200
10.78
+43.13% from price
EMA 12
15.29
+0.89% from price
EMA 26
15.00
+2.86% from price
EMA 50
14.22
+8.50% from price
RSI (14)
57.0
Neutral
MACD (12,26,9)
0.29
Hist -0.04
ATR (14)
0.50
3.23% of price
Realised vol 30D
29.9%
Annualised
Bollinger upper
15.86
20, 2σ
Bollinger lower
14.62
20, 2σ
50 / 200 cross
Golden
14.53 vs 10.78
Trend bias
Above 200
+43.13%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.82
Less volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
29.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-52.5%
Peak to trough
Max drawdown 5Y
-82.4%
Peak to trough
ATR 14
0.50
3.23% of price
Beta (reported)
0.94
5Y monthly, from filing
Short interest
Shares short
51.37M
Prior 52.19M
Change vs prior
-1.6%
Shorts covering
% of float
9.22%
Normal
% of shares out
7.60%
Against total outstanding
Days to cover
7.4
Crowded exit
Float
657.81M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 30, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 30, 26 | Stifel | MAINTAINED | Hold | Hold |
| Jul 30, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jul 30, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 8, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jun 24, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Apr 30, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 30, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Apr 15, 26 | Barclays | MAINTAINED | Underweight | Underweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-21
Corporate Changes & Voting Matters
8-K/A · 2026-08-27
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-17
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-12
Periodic Financial Reports
10-Q · 2026-04-29
Corporate Changes & Voting Matters
8-K · 2026-04-23
Headlines
VTRS vs. AVTR: Which Stock Is the Better Value Option?
Zacks · 20h ago
Q2 Earnings Review: Research Tools & Consumables Stocks Led by Avantor (NYSE:AVTR)
StockStory · 6d ago
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
PR Newswire · 6d ago
3 Unprofitable Stocks with Open Questions
StockStory · 8d ago
How Avantor’s New CFO Appointment At Avantor (AVTR) Has Changed Its Investment Story
Simply Wall St. · 15d ago
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Zacks · 16d ago
Avantor Names Todd Garner as CFO
MT Newswires · 16d ago
Avantor appoints new Chief Financial Officer
PR Newswire · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.